foxc1 as a novel prognostic biomarker in immune checkpoint inhibitor therapy
Published 1 year ago • 116 plays • Length 3:39Download video MP4
Download video MP3
Similar videos
-
5:33
cancer immune checkpoint inhibitors
-
2:07
immune checkpoint inhibitors, the next generation cancer therapy - creative biolabs
-
2:20
developing a foxc1-based immunohistochemistry assay for basal-like breast cancer
-
39:55
new checkpoints and biomarkers
-
1:50
immune checkpoint inhibitors
-
12:12
immune checkpoint proteins
-
0:46
immune checkpoint inhibitors: recent progress and potential biomarkers - 3iv pd-l1 overexpression
-
0:41
immune checkpoint inhibitors: recent progress and potential biomarkers - 6iii epigenetic signatures
-
0:35
immune checkpoint inhibitors: recent progress and potential biomarkers - 5ii genetic signatures
-
1:52
what are checkpoint inhibitors
-
0:58
what are immune checkpoints?
-
0:58
immune checkpoint inhibitors: recent progress and potential biomarkers - 3iii pd-l1 overexpression
-
3:43
tumor-infiltrating lymphocytes act as prognostic biomarkers in advanced breast cancer
-
3:30
side effects of immune checkpoint inhibitors
-
2:01
transcription factor foxo1 mediates cell survival during bcr inhibitor therapy in cll
-
0:50
cancer breakthrough! immune checkpoint inhibitor
-
14:12
adme 101 guide to subcellular fractions and when to use which test system
-
17:39
discovery of mak683, a prc2 inhibitor - drug annotations